Balaji Amines Limited
Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main products, it also have facilities for the manufacturing of derivatives, which are down-stream products for various pharma/pesticide industries apart from user specific requirements. It is one of the largest manufacturers of aliphatic amines in India.
What Balaji files
- Others52
- Investor Meet24
- Updates16
- Important12
- Board Meeting11
- PPTs9
Balaji Amines significantly advanced green initiatives, achieving Zero Liquid Discharge across all plants, securing 34% renewable power, and sharply cutting total waste. However, hazardous waste volumes rose, and GHG emissions intensified. A minor INR 46,443 customs fine for export authorization was incurred.
Balaji Amines commissioned India's first commercial Dimethyl Ether (DME) plant at its Solapur Unit-IV. With 1,00,000 TPA capacity, this advanced facility produces a vital LPG alternative for fuel and aerosol applications, aiming to reduce import dependence.
Balaji Amines has submitted its Business Responsibility and Sustainability Report for FY2024-25, highlighting key ESG strides. The company significantly improved operational efficiency, reducing energy and water intensity per unit of production and achieving Zero Liquid Discharge across all sites. Safety performance also notably enhanced with zero fatalities and fewer injuries....
Balaji Amines has announced a board meeting on the financial results for the quarter and half-year. The company has commenced commercial production of ISOPROPYLAMINE (MIPA/DIPA) at its Unit-1 plant in Osmanabad District. This specialty chemical currently serves the domestic market, with plans to explore international markets based on demand. The...
Balaji Amines has announced a board meeting to discuss the financial results for the quarter and half-year. The company has received consent to commence manufacturing of ISOPROPYLAMINE (MIPA/DIPA), with trial runs starting soon and commercial production to follow. This new product line could diversify revenue streams and enhance growth potential.